T-Cell Engager-Armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy

被引：0
|
作者：
Yu, Feng [1 ]
Gottschalk, Stephen M. [1 ]
Song, Xiao-Tong [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
410
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [41] Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
    Chen, Nanhai G.
    Yu, Yong A.
    Zhang, Qian
    Szalay, Aladar A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [42] Targeting T-cells to human cancer associated fibroblasts using an oncolytic virus expressing a FAP-specific T-cell engager
    Champion, Brian
    Freedman, Joshua
    Ashfield, Rebecca
    Duffy, Margaret
    Brown, Alice
    Seymour, Leonard
    Fisher, Kerry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [43] Constitutive HIF activity enhances T-cell antitumor immunity and memory T-cell formation in the murine adoptive cell therapy model
    Lauhan, Colette R.
    Witherden, Deborah
    Liikanan, Ilkka
    Goldrath, Ananda
    CANCER RESEARCH, 2020, 80 (14) : 46 - 47
  • [44] Tumor Specific T Cells Generated by Cytokine-Armed Oncolytic Vaccinia Virus Represent a New Therapeutic Strategy for Adoptive T Cell Transfer
    Feist, Mathilde
    Liu, Zuqiang
    Giehl, Esther
    Ma, Congrong
    Kammula, Udai
    Guo, Zong Sheng
    Bartlett, David L.
    MOLECULAR THERAPY, 2018, 26 (05) : 199 - 199
  • [45] IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer
    Deng, Lili
    Yang, Xue
    Fan, Jun
    Ding, Yuedi
    Peng, Ying
    Xu, Dong
    Huang, Biao
    Huang, Zhigang
    ONCOLOGY RESEARCH, 2020, 28 (06) : 579 - 590
  • [46] Enabling successful T-cell therapy of solid tumors with oncolytic adenoviruses armed with TNFα and IL-2
    Hemminki, A.
    Havunen, R.
    Siurala, M.
    Taehtinen, S.
    Saha, D.
    Vaehae-Koskela, M.
    Behr, M.
    Nettelbeck, D.
    Ehrhardt, A.
    Parviainen, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Mechanisms of resistance to bispecific T-cell engager therapy for ovarian cancer
    Barakzai, Syem
    Xu, Mengyao
    Veillard, Irva
    Matoba, Yusuke
    Kononenko, Artem
    Kim, Eugene
    Bregar, Amy
    Eisenhauer, Eric L.
    Penson, Richard T.
    Bouberhan, Sara
    Colella, Tina
    Clark, Caroline
    Castro, Cesar Martin
    Spriggs, David R.
    Rueda, Bo R.
    Yeku, Oladapo O.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy
    Noguchi, Yoshihiro
    Yan, Miao
    Tachi, Tomoya
    Yoshimura, Tomoaki
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [49] Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy
    Marar, Rosalyn I. I.
    Abbasi, Muhannad Aboud
    Prathivadhi-Bhayankaram, Sruti
    Daryanani, Andres
    Villarraga, Hector
    Anavekar, Nandan
    Bhatt, Vijaya Raj
    Paludo, Jonas
    JCO ONCOLOGY PRACTICE, 2023, 19 (06) : 331 - +
  • [50] Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
    Baugh, Richard
    Khalique, Hena
    Page, Emma
    Lei-Rossmann, Janet
    Wan, Peter Kok-Ting
    Johanssen, Timothy
    Ebner, Daniel
    Ansorge, Olaf
    Seymour, Leonard W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
12345